efaproxiral has been researched along with Heart Disease, Ischemic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bottomley, PA; Gerstenblith, G; Najjar, SS; Schulman, SP; Steffen, RP; Waldron, MM; Weiss, RG | 1 |
| Babcock, EE; Malloy, CR; Storey, CJ; Woods, JA | 1 |
| Hettrick, DA; Kersten, JR; Montgomery, MW; Pagel, PS; Steffen, RP; Warltier, DC | 1 |
| Hettrick, DA; Kersten, JR; Montgomery, MW; Pagel, PS; Warltier, DC | 1 |
| Becker, LC; Chacko, VP; DiPaula, AF; Gerstenblith, G; Kass, DA; Mejia, MA; Weiss, RG | 1 |
1 trial(s) available for efaproxiral and Heart Disease, Ischemic
| Article | Year |
|---|---|
Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery disease.
Topics: Adenosine Triphosphate; Aged; Analysis of Variance; Aniline Compounds; Antisickling Agents; Biomarkers; Blood Flow Velocity; Coronary Artery Disease; Coronary Circulation; Cross-Over Studies; Double-Blind Method; Exercise Test; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Oxyhemoglobins; Phosphocreatine; Phosphorus Isotopes; Propionates; Treatment Outcome | 2005 |
4 other study(ies) available for efaproxiral and Heart Disease, Ischemic
| Article | Year |
|---|---|
Right-shifting the oxyhemoglobin dissociation curve with RSR13: effects on high-energy phosphates and myocardial recovery after low-flow ischemia.
Topics: Aniline Compounds; Animals; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Myocardial Ischemia; Oxyhemoglobins; Phosphates; Propionates; Rats; Rats, Sprague-Dawley | 1998 |
RSR13, a synthetic modifier of hemoglobin-oxygen affinity, enhances the recovery of stunned myocardium in anesthetized dogs.
Topics: Anesthesia; Aniline Compounds; Animals; Antisickling Agents; Blood Pressure; Dogs; Female; Hemodynamics; Hemoglobins; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Stunning; Oxygen; Propionates | 1998 |
RSR13, a synthetic allosteric modifier of hemoglobin, enhances recovery of stunned myocardium in dogs.
Topics: Allosteric Regulation; Analysis of Variance; Aniline Compounds; Animals; Antisickling Agents; Coronary Circulation; Dogs; Female; Heart; Hemodynamics; Hemoglobins; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Stunning; Propionates; Regional Blood Flow | 1998 |
Preservation of canine myocardial high-energy phosphates during low-flow ischemia with modification of hemoglobin-oxygen affinity.
Topics: Aniline Compounds; Animals; Antisickling Agents; Dogs; Hemoglobins; Myocardial Ischemia; Oxygen; Oxygen Consumption; Phosphocreatine; Propionates | 1999 |